Latest in Pulmonary News

Thirty-Day Hospital Readmission Metric Linked to Increased Mortality for HF and Pneumonia

Physicians are at increased pressure to reduce readmissions for certain chronic diseases. A recent study found that implementation of the 30-day readmission rules has been associated with increased 30-day post-discharge mortality for those hospitalized for heart failure and pneumonia.

Post-discharge deaths have increased by 0.25% for patients hospitalized with heart failure and by 0.40% for patients with pneumonia since the implementation of the 30-day readmission rules.
There are approximately 8 million hospitalizations during the study period. Such small increases may account for a large number of deaths.

The findings, published online in JAMA, come from a retrospective cohort study that compared mortality rates among 8.3 million Medicare beneficiaries hospitalized for these common conditions before and after implementation of the Hospital Readmissions Reduction Program (HRRP). This early data should lead physicians to exercise caution in discharging patients prematurely.

Source: Association of the Hospital Readmissions Reduction Program With Mortality Among Medicare Beneficiaries Hospitalized for Heart Failure, Acute Myocardial Infarction, and Pneumonia. JAMA. 2018;320(24):2542-2552. doi:10.1001/jama.2018.19232

Add Corticosteroids to Your Arsenal for the treatment of Inpatient Community-Acquired Pneumonia.

Corticosteroids were both beneficial and cost-effective for hospitalized adults with severe CAP. Hospitalized people with non-severe CAP may also benefit from corticosteroid therapy, but with no survival advantage

In 2015, results of two randomized trials showed that systemic corticosteroids were beneficial for some hospitalized patients with community-acquired pneumonia (CAP; NEJM JW Gen Med Mar 15 2015 and JAMA 2015; 313:677; NEJM JW Gen Med Mar 1 2015 and Lancet 2015; 385:1511). Now, two new meta-analyses — one by the Cochrane Library, and one by the Infectious Diseases Society of America (IDSA) — address whether CAP patients should receive systemic corticosteroids routinely.

These meta-analyses suggest that low-dose (≈40 mg), short-course (3–7 days) systemic corticosteroids should be strongly considered for hospitalized adults with severe CAP. These results do not apply to outpatients with CAP or to inpatients with hospital-acquired pneumonia or ventilator-associated pneumonia. Several ongoing randomized trials probably will clarify steroid use further for pneumonia indications.

Source:
The Cost-effectiveness of Corticosteroids for the treatment of Community-Acquired Pneumonia
Chest. 2018 Nov 15. pii: S0012-3692(18)32727-2. doi: 10.1016/j.chest.2018.11.001.
https://www.ncbi.nlm.nih.gov/pubmed/30448195?dopt=Abstract

Home oxygen therapy for COPD: Does it matter whether the patient is hypoxemic? Evidence vs Reality

Home oxygen therapy for COPD: Does it matter whether the patient is hypoxemic? Evidence vs Reality?

Long-term oxygen therapy (LTOT) is given to improve survival time in people with COPD and severe chronic hypoxemia at rest. The efficacy of oxygen therapy for breathlessness and health-related quality of life (HRQOL) in people with COPD and mild or no hypoxemia who do not meet the criteria for LTOT has not been established. Scientific evidence for its benefits of LTOT dates back to the 1980s when two randomized controlled trials showed prolonged survival in COPD-patients undergoing LTOT for at least 15 hours/day. In contrast, the potential benefits of LTOT in non-COPD-patients has not been well researched and the recommendations for its application are primarily extrapolated from trials on COPD-patients.

Recent Cochrane analysis found that oxygen can relieve breathlessness when given during exercise to mildly hypoxaemic and non-hypoxaemic people with chronic obstructive pulmonary disease who would not otherwise qualify for home oxygen therapy. Findings show that COPD patients without severe hypoxemia undergoing oxygen therapy during exercise training over time do not achieve better exercise capacity or health-related quality of life compared with placebo.

However, LTOT has a beneficial effect on quality of life, dyspnea, and exercise capacity in patients with COPD and exertional hypoxemia.

Source:
Oxygen for breathlessness in patients with chronic obstructive pulmonary disease who do not qualify for home oxygen therapy
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006429.pub3/full

J Bras Pneumol. 2018 Sep-Oct;44(5):390-397. doi: 10.1590/S1806-37562017000000019.
Impact of adherence to long-term oxygen therapy on patients with COPD and exertional hypoxemia followed for one year.
https://www.ncbi.nlm.nih.gov/pubmed/30517340

Latest in Pulmonary Research

  1. Μachairoudia, G, Kazantzis, D, Negretti, GS, Sagoo, MS. Intraocular Metastasis: Differential Diagnosis and Management. Clin Exp Ophthalmol. 2026; :. doi: 10.1111/ceo.70100. PubMed PMID:41793166 .
  2. Deng, H, Guo, B, Chen, G, Li, Q, Feng, D, Yang, C et al.. Pulmonary intravascular large B-cell lymphoma misdiagnosed as allergic pneumonia: a case report and literature review. Ther Adv Respir Dis. 2026;20 :17534666261424374. doi: 10.1177/17534666261424374. PubMed PMID:41793148 .
  3. Li, J, Xu, L, Yao, N, Mao, J, Zhao, H. A model of coagulation-related genes for prediction of prognosis in lung adenocarcinoma and verification in vitro. Sci Prog. 2026;109 (1):368504261426216. doi: 10.1177/00368504261426216. PubMed PMID:41793132 .
  4. Huhtinen, T, Laurikkala, M, Heinävaara, S, Murtola, TJ, Ilmonen, P. On Cluster Structures of Finnish Cancer Incidence Data. Cancer Control. 2026;33 :10732748261419587. doi: 10.1177/10732748261419587. PubMed PMID:41793103 .
  5. Hung, CT, An, CY, Gong, J, Suk, CW, Lee, YJ, Hung, SH et al.. Association Between Asthma Biologics and Risk of Herpes Zoster Among US Adults With Asthma: A Pairwise Comparison. Clin Exp Allergy. 2026; :. doi: 10.1111/cea.70268. PubMed PMID:41792975 .
  6. Cattani, AC, Bhaskaran, JG, Ali, F, Stierwalt, J, Agosta, F, Filippi, M et al.. Longitudinal Videofluorographic Dysphagia Measures in Progressive Supranuclear Palsy. Mov Disord Clin Pract. 2026; :. doi: 10.1002/mdc3.70584. PubMed PMID:41792957 .
  7. Zheng, H, Wang, Q, Wang, M, Luo, S, Ma, Y, Wan, Z et al.. Case Report: Co-Occurrence of Lung Adenocarcinoma and Congenital Dysfibrinogenemia-Diagnostic and Perioperative Management Challenges. Cancer Rep (Hoboken). 2026;9 (3):e70512. doi: 10.1002/cnr2.70512. PubMed PMID:41792928 .
  8. Jansson, M, Bark, R, Elliot, A, Hammarstedt-Nordenvall, L, Gahm, C. Distribution of Sentinel Nodes in Non-Parotid Salivary Gland Tumors-A Feasibility Study. Cancer Rep (Hoboken). 2026;9 (3):e70510. doi: 10.1002/cnr2.70510. PubMed PMID:41792918 .
  9. Wanas, H, Khalifa, AK, Elbadawy, HM, Hamoud, AE, Almikhlafi, MA, Albadawi, EA et al.. Targeting Inflammatory and Oxidative Pathways in Idiopathic Pulmonary Fibrosis: Synergistic Effects of Quercetin and Pirfenidone in Modulating Nrf2/PPAR-γ and TLR-4/NF-κB Pathways. Pharmacol Res Perspect. 2026;14 (2):e70229. doi: 10.1002/prp2.70229. PubMed PMID:41792874 .
  10. Grofvert, J, Van Rossum, B, Pettijohn, E, Mobayed, M, Stonerock, D. Effective high-dose methotrexate toxicity reversal using fixed-dose glucarpidase in obese patients: a case series. J Med Case Rep. 2026; :. doi: 10.1186/s13256-025-05774-2. PubMed PMID:41792836 .
  11. Li, S, Li, H, Wu, J, Cheng, L, Zhang, G, Ma, T et al.. Heterogeneous associations between molecular subtypes of small cell lung cancer and survival prognosis: a systematic review highlighting knowledge gaps. Eur J Med Res. 2026; :. doi: 10.1186/s40001-026-04052-1. PubMed PMID:41792831 .
  12. Jo, E, Bae, S, Ryu, SH, Park, S, Kim, M, Kim, JY et al.. Effectiveness of toothbrushing as a replacement for chlorhexidine in oral care, combined with head elevation for the prevention of ventilator-associated pneumonia in intensive care units: interrupted time-series analysis. Crit Care. 2026; :. doi: 10.1186/s13054-026-05936-8. PubMed PMID:41792818 .
  13. Lee, WJ, Jo, EJ, Park, HK. Hydroxypropyl methylcellulose-induced urticaria and angioedema: a case report. Allergy Asthma Clin Immunol. 2026; :. doi: 10.1186/s13223-026-01021-5. PubMed PMID:41792785 .
  14. Schröder, LJ, Rückoldt, J, Schubert, S, Knudsen, L, Janciauskiene, SM, Werlein, C et al.. Optimized culture of primary human alveolar type II cell-derived 3D organoids from fibrotic lung tissue with phenotypic and metabolic profiling. Respir Res. 2026; :. doi: 10.1186/s12931-026-03610-9. PubMed PMID:41792753 .
  15. Fang, J, Deng, M, Li, Z, Lai, H, Lai, R, Chen, H et al.. Analysis of the evolution mechanism of in-host drug resistance of Klebsiella pneumoniae during treatment with tigecycline, eravacycline and Polymyxin B. Ann Clin Microbiol Antimicrob. 2026; :. doi: 10.1186/s12941-025-00841-4. PubMed PMID:41792741 .
  16. He, W, Feng, C, Liu, M, Qin, H, Wu, Y, Deng, C et al.. Decoding the ubiquitination-immunity axis in idiopathic pulmonary fibrosis: diagnostic insights and therapeutic implications. Respir Res. 2026; :. doi: 10.1186/s12931-026-03612-7. PubMed PMID:41792712 .
  17. Zhang, M, Liu, Q, Ju, L, Zheng, Y, Dou, K, Chen, W et al.. Multi-omics integration identifies associations between large high-density lipoprotein and lung function, asthma, and COPD: evidence from genetic and population-based analyses. Respir Res. 2026; :. doi: 10.1186/s12931-026-03562-0. PubMed PMID:41792706 .
  18. Zhao, R, Zeng, H, Chen, Y. From early smoking to COPD and other chronic respiratory disease: unraveling the roles of chemical pollutants and underlying toxicological mechanisms. BMC Pulm Med. 2026; :. doi: 10.1186/s12890-026-04229-8. PubMed PMID:41792688 .
  19. Jalal, L, Aksakal, A, Kerget, B, Uçar, EY, Araz, Ö, Sağlam, L et al.. Effects of combined inspiratory muscle training and positive expiratory pressure therapy on pulmonary function, respiratory muscle strength, exercise capacity and dyspnea in stable group E COPD patients. BMC Pulm Med. 2026; :. doi: 10.1186/s12890-025-04078-x. PubMed PMID:41792683 .
  20. Li, S, Huang, M, Jia, L, Liu, S, Sun, X, Cai, D et al.. In silico design of the multi-epitope vaccine for lung adenocarcinoma based on hub gene-derived neoantigens. BMC Cancer. 2026; :. doi: 10.1186/s12885-026-15765-1. PubMed PMID:41792674 .
  21. Sultana, S, Zhang, H, Jiang, Y, Abrar, MNF, Arshad, H, Xie, L et al.. Impact of influential data on screening epigenome-wide data. BMC Bioinformatics. 2026; :. doi: 10.1186/s12859-026-06369-4. PubMed PMID:41792594 .
  22. Lee, HH, Avery, CL, Graff, M, Kim, D, Arias, J, Van Horn, L et al.. Impact of Genetic Predisposition to Obesity on Long-Term Maintenance of Modest Weight Loss in Postmenopausal Women. Obesity (Silver Spring). 2026; :. doi: 10.1002/oby.70175. PubMed PMID:41792585 .
  23. Jiang, Z, Liu, T, Lu, K, Cheng, Y, Wang, S, Shao, D et al.. PET/CT predict pathological response to neoadjuvant nivolumab in resectable non-small cell lung cancer. Eur J Nucl Med Mol Imaging. 2026; :. doi: 10.1007/s00259-026-07822-5. PubMed PMID:41792564 .
  24. Liu, Z, Sun, R, Li, Y, Zhang, Z, Huang, P, Zhou, Y et al.. Dexamethasone promotes neutrophil ROS-mediated tumor killing through the glucocorticoid receptor. Oncogene. 2026; :. doi: 10.1038/s41388-026-03708-w. PubMed PMID:41792468 .
  25. Kawai, K, Matsumoto, S, Harada, A, Sada, R, Harada, T, Kasahara, Y et al.. Development of ARL4C antisense oligonucleotide with reduced off-target effects and enhanced efficacy as an anti-cancer drug. In Vitro Cell Dev Biol Anim. 2026; :. doi: 10.1007/s11626-026-01154-2. PubMed PMID:41792408 .
Search PubMed

Search Terms: Asthma, COPD, Lung Cancer, Pneumonia, Pulmonary Fibrosis

Back to top